Clinical Trial Update: Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating tamoxifen or letrozole for ductal carcinoma in situ completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Drugs mentioned

• Letrozole (letrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: University of California, San Francisco | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-12-04